Your browser doesn't support javascript.
loading
Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer.
Wu, Natalie L; Chen, Yan; Dieffenbach, Bryan V; Ehrhardt, Matthew J; Hingorani, Sangeeta; Howell, Rebecca M; Jefferies, John L; Mulrooney, Daniel A; Oeffinger, Kevin C; Robison, Leslie L; Weil, Brent R; Yuan, Yan; Yasui, Yutaka; Hudson, Melissa M; Leisenring, Wendy M; Armstrong, Gregory T; Chow, Eric J.
Afiliação
  • Wu NL; Division of Oncology, Department of Pediatrics, University of California San Francisco Benioff Children's Hospital, Oakland, CA.
  • Chen Y; Division of Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, WA.
  • Dieffenbach BV; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Ehrhardt MJ; Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Hingorani S; Department of Surgery, Boston Children's Hospital, Boston, MA.
  • Howell RM; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN.
  • Jefferies JL; Division of Hematology/Oncology, Department of Pediatrics, University of Washington, Seattle Children's Hospital, Seattle, WA.
  • Mulrooney DA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Oeffinger KC; Division of Radiation Oncology, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Robison LL; Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN.
  • Weil BR; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN.
  • Yuan Y; Department of Medicine, Duke University, Durham, NC.
  • Yasui Y; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN.
  • Hudson MM; Department of Surgery, Boston Children's Hospital, Boston, MA.
  • Leisenring WM; Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
  • Armstrong GT; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN.
  • Chow EJ; Department of Epidemiology and Cancer Control, St Jude Children's Research Hospital, Memphis, TN.
J Clin Oncol ; 41(12): 2258-2268, 2023 04 20.
Article em En | MEDLINE | ID: mdl-36795981
ABSTRACT

PURPOSE:

Kidney failure is a rare but serious late effect following treatment for childhood cancer. We developed a model using demographic and treatment characteristics to predict individual risk of kidney failure among 5-year survivors of childhood cancer.

METHODS:

Five-year survivors from the Childhood Cancer Survivor Study (CCSS) without history of kidney failure (n = 25,483) were assessed for subsequent kidney failure (ie, dialysis, kidney transplantation, or kidney-related death) by age 40 years. Outcomes were identified by self-report and linkage with the Organ Procurement and Transplantation Network and the National Death Index. A sibling cohort (n = 5,045) served as a comparator. Piecewise exponential models accounting for race/ethnicity, age at diagnosis, nephrectomy, chemotherapy, radiotherapy, congenital genitourinary anomalies, and early-onset hypertension estimated the relationships between potential predictors and kidney failure, using area under the curve (AUC) and concordance (C) statistic to evaluate predictive power. Regression coefficient estimates were converted to integer risk scores. The St Jude Lifetime Cohort Study and the National Wilms Tumor Study served as validation cohorts.

RESULTS:

Among CCSS survivors, 204 developed late kidney failure. Prediction models achieved an AUC of 0.65-0.67 and a C-statistic of 0.68-0.69 for kidney failure by age 40 years. Validation cohort AUC and C-statistics were 0.88/0.88 for the St Jude Lifetime Cohort Study (n = 8) and 0.67/0.64 for the National Wilms Tumor Study (n = 91). Risk scores were collapsed to form statistically distinct low- (n = 17,762), moderate- (n = 3,784), and high-risk (n = 716) groups, corresponding to cumulative incidences in CCSS of kidney failure by age 40 years of 0.6% (95% CI, 0.4 to 0.7), 2.1% (95% CI, 1.5 to 2.9), and 7.5% (95% CI, 4.3 to 11.6), respectively, compared with 0.2% (95% CI, 0.1 to 0.5) among siblings.

CONCLUSION:

Prediction models accurately identify childhood cancer survivors at low, moderate, and high risk for late kidney failure and may inform screening and interventional strategies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumor de Wilms / Insuficiência Renal / Sobreviventes de Câncer / Neoplasias Renais / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tumor de Wilms / Insuficiência Renal / Sobreviventes de Câncer / Neoplasias Renais / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article